Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/34905
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGarcia-Arumi, Jose
dc.contributor.authorGómez-Ulla, Francisco
dc.contributor.authorAmparo, Navea
dc.contributor.authorCervera, Enrique
dc.contributor.authorFonollosa, Alex
dc.contributor.authorArias, Luis
dc.contributor.authorAraiz, Javier
dc.contributor.authorDonate, Juan
dc.contributor.authorde Figueroa, Marta Suárez
dc.contributor.authorManzanas, Lucia
dc.contributor.authorCrespí, Jaume
dc.contributor.authorGallego, Roberto
dc.date.accessioned2019-06-28T17:43:50Z-
dc.date.available2019-06-28T17:43:50Z-
dc.date.issued2018
dc.identifier.citationJ Ophthalmol.2018;(2018):8310350
dc.identifier.issn2090-004X
dc.identifier.urihttps://hdl.handle.net/20.500.12530/34905-
dc.description.abstractTo evaluate efficacy and safety of an aflibercept treat-and-extend (TAE) regimen in patients with macular oedema (MO) secondary to central retinal vein occlusion (CRVO).
dc.language.isoeng
dc.rightsopenAccess-
dc.titleEfficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial.
dc.typeArtículo
dc.identifier.pubmedID30405907
dc.format.volume2018
dc.format.page8310350
dc.identifier.journalJournal of ophthalmology
dc.identifier.doi10.1155/2018/8310350
dc.identifier.pmcPMC6204200
dc.pubmedtypeJournal Article
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:
File Description SizeFormat 
PMC6204200.pdf1.09 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.